Mineralys Therapeutics, Inc. (MLYS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Mineralys Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -15.88x | -3.36x | -4.33x | -3.20x | -4.74x | -24.92x |
| P/B Ratio | 3.80x | 3.12x | 1.29x | -1.82x | -4.01x | -23.74x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 43.76x | 14.02x | 23.76x | 13.98x | 2.20x | 0.29x |
| Quick Ratio | 43.76x | 14.02x | 23.76x | 13.98x | 2.20x | 0.29x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | -1.25x |
YoY = year-over-year change. Source: FMP..